Qynapse is thrilled to be part of the Scientific Program of AAIC and the Virtual Exhibition from July 27 to July 31 − to present our latest advances and solutions.
This author has yet to write their bio.Meanwhile lets just say that we are proud ysalledechou contributed a whooping 23 entries.
Entries by ysalledechou
QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Qynapse is pleased to sponsor #ACTRIMSForum 2021 – established to advance the research and clinical care of multipl… https://t.co/KJPuq7p83I15 hours ago
- As a founding member of the Decentralized Trials & Research Alliance @DTRAorg, we look forward to the collaboration… https://t.co/MkPrmyZmiu30 days ago
- Qynapse wishes you a Happy New Year 2021! We look forward to continue with exciting collaborations this year – to d… https://t.co/fMjDxQFUq851 days ago
- By advancing #decentralizedtrials we can make clinical trials more patient-focused, diverse and efficient, and leve… https://t.co/z8ck93CH7Y56 days ago
130, rue de Lourmel
75015 Paris – France